Quick Search

 

 


 

 

Result Summary for 114554

Result Summary
Protocol ID: 114554
Clinical Study ID: STF114554
Official Title: A phase 2, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in subjects with distal subungual onychomycosis
Phase: phase 2
Study Indications or Diseases:
  • Onychomycosis
Generic Name: albaconazole
Trade/Product Name: albaconazole
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.